Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jukka Westermarck

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Genome Medicine|September 9, 2010
Large-scale data integration framework provides a comprehensive view on glioblastoma multiformeKristian Ovaska, Marko Laakso, Saija Haapa-Paananen, et al.
EMBO Reports|October 28, 2022
CIP2A deficiency promotes depression-like behaviors in mice through inhibition of dendritic arborizationWen-Ting Hu, Zhen-Yu Liuyang, Yuan Tian, et al.
Cell Reports|July 4, 2024
Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growthOpeyemi Olotu, Anna-Riina Koskenniemi, Lin Ma, et al.
The Journal of Biological Chemistry|February 20, 2020
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1Otto Kauko, Susumu Y Imanishi, Evgeny Kulesskiy, et al.
Oncogene|September 22, 2019
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitorsCaitlin M O'Connor, Daniel Leonard, Danica Wiredja, et al.
Cancer Research|February 8, 2020
<i>UBR5</i> Is Coamplified with <i>MYC</i> in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent ApoptosisXi Qiao, Ying Liu, Maria Llamazares Prada, et al.
Cancer Discovery|January 12, 2013
Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1Anni Laine, Harri Sihto, Christophe Come, et al.
EMBO Molecular Medicine|July 17, 2025
LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancerXi Qiao, Johannes Routila, Mari Tienhaara, et al.
Nature Communications|February 28, 2023
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2AKarolina Pavic, Nikhil Gupta, Judit Domènech Omella, et al.
Cancer Research|September 28, 2013
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cellsAnchit Khanna, Otto Kauko, Camilla Böckelman, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Genome Medicine|September 9, 2010
Large-scale data integration framework provides a comprehensive view on glioblastoma multiformeKristian Ovaska, Marko Laakso, Saija Haapa-Paananen, et al.
EMBO Reports|October 28, 2022
CIP2A deficiency promotes depression-like behaviors in mice through inhibition of dendritic arborizationWen-Ting Hu, Zhen-Yu Liuyang, Yuan Tian, et al.
Cell Reports|July 4, 2024
Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growthOpeyemi Olotu, Anna-Riina Koskenniemi, Lin Ma, et al.
The Journal of Biological Chemistry|February 20, 2020
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1Otto Kauko, Susumu Y Imanishi, Evgeny Kulesskiy, et al.
Oncogene|September 22, 2019
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitorsCaitlin M O'Connor, Daniel Leonard, Danica Wiredja, et al.
Cancer Research|February 8, 2020
<i>UBR5</i> Is Coamplified with <i>MYC</i> in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent ApoptosisXi Qiao, Ying Liu, Maria Llamazares Prada, et al.
Cancer Discovery|January 12, 2013
Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1Anni Laine, Harri Sihto, Christophe Come, et al.
EMBO Molecular Medicine|July 17, 2025
LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancerXi Qiao, Johannes Routila, Mari Tienhaara, et al.
Nature Communications|February 28, 2023
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2AKarolina Pavic, Nikhil Gupta, Judit Domènech Omella, et al.
Cancer Research|September 28, 2013
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cellsAnchit Khanna, Otto Kauko, Camilla Böckelman, et al.
Pageof 10